Phase 3 Hearing Loss Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy
Hearing Loss Mixed
Nuance Hearing89 enrolled1 locationNCT07282028
Recruiting
Phase 3
Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial
Cisplatin-related Hearing Loss
The Netherlands Cancer Institute100 enrolled5 locationsNCT07281508
Withdrawn
Phase 2Phase 3
Randomised controlled trial comparing conventional steroid treatment to conventional steroids plus hyperbaric oxygen treatment in sudden sensorineural hearing loss within two weeks of onset.
Sudden idiopathic sensorineural hearing loss
University of Queensland100 enrolled6 locationsACTRN12619001495112